However, concurring with European‐biased data, African tumours were commonly mutated for TP53 (52.2%), SHBG (49.6%), PTEN (38.9%), FOXP1 (20.4%), FOXA1 (19.5%), and SPOP (10.6%), and while at lower frequencies CDK12 (6.2%) and CSMD3 (9.7%) were 3.9 and 2‐fold more likely to be mutated in African tumours, respectively.7 The gene discussed is CSMD3; the disease is neoplasm.